Benzodiazepine-induced spatial learning deficits in rats are regulated by the degree of modulation of α1 GABA(A) receptors.
Despite significant advances in understanding the role of benzodiazepine (BZ)-sensitive populations of GABAA receptors, containing the α1, α2, α3 or α5 subunit, factual substrates of BZ-induced learning and memory deficits are not yet fully elucidated. It was shown that α1-subunit affinity-selective antagonist β-CCt almost completely abolished spatial learning deficits induced by diazepam (DZP) in the Morris water maze. We examined a novel, highly (105 fold) α1-subunit selective ligand-WYS8 (0.2, 1 and 10 mg/kg), on its own and in combination with the non-selective agonist DZP (2 mg/kg) or β-CCt (5 mg/kg) in the water maze in rats. The in vitro efficacy study revealed that WYS8 acts as α1-subtype selective weak partial positive modulator (40% potentiation at 100nM). Measurement of concentrations of WYS8 and DZP in rat serum and brain tissues suggested that they did not substantially cross-influence the respective disposition. In the water maze, DZP impaired spatial learning (acquisition trials) and memory (probe trial). WYS8 caused no effect per se, did not affect the overall influence of DZP on the water-maze performance and was devoid of any activity in this task when combined with β-CCt. Nonetheless, an additional analysis of the latency to reach the platform and the total distance swam suggested that WYS8 addition attenuated the run-down of the spatial impairment induced by DZP at the end of acquisition trials. These results demonstrate a clear difference in the influence of an α1 subtype-selective antagonist and a partial agonist on the effects of DZP on the water-maze acquisition.
Medicines and Medical Devices Agency of Serbia, Biological Laboratory-Pharmacology, Belgrade, Serbia.
Srđan
S
Joksimović
Jovana
J
Divljaković
Michael L
ML
Van Linn
Zdravko
Z
Varagic
Gordana
G
Brajković
Marija M
MM
Milinković
Wenyuan
W
Yin
Tamara
T
Timić
Werner
W
Sieghart
James M
JM
Cook
Miroslav M
MM
Savić
D000818:Animals; D001569:Benzodiazepines / Q000633:toxicity*; D005260:Female; D018757:GABA Modulators / Q000633:toxicity; D008297:Male; D018782:Maze Learning / Q000187:drug effects / Q000502:physiology*; D008569:Memory Disorders / Q000139:chemically induced* / Q000503:physiopathology; D051381:Rats; D017208:Rats, Wistar; D011963:Receptors, GABA-A / Q000502:physiology*; D013037:Spatial Behavior / Q000187:drug effects / Q000502:physiology*; D014982:Xenopus laevis
D018757:GABA Modulators; C546242:Gabra1 protein, rat; D011963:Receptors, GABA-A; D001569:Benzodiazepines